Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Mighty microexons take center stage in shaping of the brain

  • New imaging tool targets degenerative diseases

  • Publication bias and 'spin' raise questions about drugs for anxiety disorders

  • World first study reveals antibodies that may trigger psychosis in children

  • Poses of power are less powerful than we thought

  • Well-designed classrooms can boost learning progress in primary school pupils by up to 16% in a single year, research reveals

  • Interview blues: Anxious, slow talkers often do not get the job

  • Depression often co-occurs with joint diseases

  • Negotiating: Careful Choice of Words Increases Chances of Success

  • Insight creates new memories in the brain

  •